Raising the bar: optimizing combinations of targeted therapy and immunotherapy

Ann Transl Med. 2015 Oct;3(18):272. doi: 10.3978/j.issn.2305-5839.2015.10.28.

Authors

Alexandre Reuben¹, Jacob Austin-Breneman¹, Jennifer A Wargo¹, Zachary A Cooper¹

Affiliation

¹ 1 Department of Surgical Oncology; 2 Department of Genomic Medicine, the University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

PMID: 26605318
PMCID: PMC4630548
DOI: 10.3978/j.issn.2305-5839.2015.10.28

No abstract available